Development and Validation of a New Digital Dermatoscope in the United States
NCT ID: NCT04047316
Last Updated: 2020-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2019-08-27
2020-04-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optical Spectroscopy for Cutaneous Cancer
NCT02522793
At-Home Dermoscopy Artificial Intelligence
NCT05321784
Skin Tumor Biomarkers by Mass Spectrometry Imaging
NCT06227416
In Vivo Confocal Microscopy of Cutaneous Neoplasms and Normal Skin
NCT00588315
Fast Track Diagnosis of Skin Cancer by Advanced Imaging Technologies and Tumour Tapestripping
NCT05389085
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Digital dermoscopy
Acquire skin images with a new digital dermatoscope
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or Female, aged 18 years or above.
* Male or Female, aged less than 18 years, with informed consent of their legally authorized representative.
* Patient presenting with any visible skin lesion for dermatologist review on a body site amenable to optimal photographic imaging.
* Able and willing to comply with all study requirements.
* Patient with a skin lesion that is clinically diagnosed by a dermatologist as benign, malignant or a suspicious skin lesion requiring excisional biopsy for histological diagnosis.
Exclusion Criteria
* Patients unable to provide informed consent.
* Skin lesions in an anatomical site which is not suitable for photography including hair-obscured site, subungual lesion or inaccessible mucosal site.
* Lesion is at a site where previous surgery was undertaken.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Barco NV
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dermatologic Surgery Center of Washington LLC
Chevy Chase, Maryland, United States
Silver Falls Dermatology
Salem, Oregon, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CI-PROT-0029
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.